Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients.
Keay
S
S
Department of Medicine, Stanford University School of Medicine, California 94305.
Bissett
J
J
Merigan
T C
TC
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy*; D005260:Female; D015774:Ganciclovir; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000150:complications; D011024:Pneumonia, Viral / Q000150:complications / Q000188:drug therapy; D013724:Teratoma / Q000150:complications
D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir